Viskase Holdings, Inc.

VISK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $7.5M $7.6M $11.7M $34.6M $6.5M $77.3M $104.3M $397.5M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $7.6M $7.9M $11.8M $35.0M $7.1M $198.6M $165.3M $434.6M
Property, Plant & Equipment — — — — $0 $1.1M $16.8M $21.6M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $9.5M $11.3M $22.9M $35.0M $7.1M $199.8M $343.2M $488.9M
Liabilities
Accounts Payable $225.0K $770.0K $90.0K $181.0K $93.0K $776.0K $1.6M $4.2M
Total Current Liabilities $368.0K $940.0K $4.8M $5.1M $1.3M $122.3M $15.3M $18.4M
Long-Term Debt — — — — — — — —
Total Liabilities $368.0K $940.0K $4.8M $5.4M $1.9M $122.3M $146.0M $157.0M
Stockholders' Equity
Retained Earnings $-74.9M $-80.4M $-79.3M $-100.9M $-129.7M $-147.8M $-145.1M $-124.3M
Total Stockholders' Equity $9.1M $10.3M $18.1M $29.6M $5.3M $77.5M $197.2M $331.9M
← Newer Page 2 of 2 Older →